United States v. Lillian Akwuba

Court of Appeals for the Eleventh Circuit·Decided October 4, 2023·No. 22-11917·Unpublished

Opinion

[DO NOT PUBLISH]

In the

United States Court of Appeals For the Eleventh Circuit

No. 22-11917

Non-Argument Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus LILLIAN AKWUBA,

Defendant-Appellant.

Appeal from the United States District Court for the Middle District of Alabama D.C. Docket No. 2:17-cr-00511-WKW-SRW-1

2 Opinion of the Court 22-11917

Before WILSON, NEWSOM, and GRANT, Circuit Judges. PER CURIAM:

Defendant-Appellant Lillian Akwuba appeals her convictions for distribution of and conspiracy to distribute controlled substances in violation of 21 U.S.C. §§ 841(a)(1) and 846, respectively. She challenges both the jury instructions and the sufficiency of the evidence. First, she argues that the jury was improperly instructed as to the applicable good faith standard for a conviction under 21 U.S.C. § 841. She also argues that the jury instructions were erroneous because they did not adequately convey to the jury that the knowing and intentional mens rea applied not only to the actus reus of the same statute, but also to its authorization clause. Second, she argues that the government did not provide sufficient evidence of her mens rea to support her convictions under 21 U.S.C. §§ 841 and 846. After a thorough review of the record, we affirm Akwuba’s convictions and sentences.

I. Background

In a fourth superseding indictment, the grand jury charged Akwuba with conspiring to distribute controlled substances, in violation of 21 U.S.C. § 846 (count 1); unlawfully distributing controlled substances at Gilberto Sanchez’s Family Practice, in violation of 21 U.S.C. § 841(a)(1) (counts 2–11); conspiring to commit health care fraud, in violation of 18 U.S.C. § 1349 (count 13); health care fraud relating to office visits, in violation of 18 U.S.C. § 1347 (counts 14–20); health care fraud relating to prescriptions, in

22-11917 Opinion of the Court 3

violation of 18 U.S.C. § 1347 (counts 21–27); conspiracy to commit money laundering, in violation of 18 U.S.C. § 1956 (count 39); money laundering, in violation of 18 U.S.C. § 1957 (counts 40–42); and unlawfully distributing controlled substances at Akwuba’s own Mercy Family Health Care, in violation of 21 U.S.C. § 841(a)(1) (counts 44–53). Akwuba pled not guilty and proceeded to trial. The government dismissed counts 8, 14, 19–21, 26, 27, 49 and 52 before trial, and counts 16, 18, 23, and 25 during trial.

Both the government and Akwuba were consulted by the district court in deciding the proper jury instructions. In pertinent part, the jury instructions related to subjective good faith, prescribing regulations in 21 C.F.R. § 1306.04, and unlawfully distributing a controlled substance read as follows:

The good faith of a defendant, whether or not objectively reasonable, is a complete defense to the crimes charged. That is because good faith on the part of a defendant is inconsistent with specific intent, which is an essential part of the charge. . . . In the practice of medicine, good faith means the honest exercise of good professional judgment as to a patient’s medical needs. Good faith connotes an honest effort to treat patients in compliance with generally recognized and accepted standards of medical practice. . . .

. . . [I]f the government proves beyond a reasonable doubt that a prescription was knowingly written and issued, one, not for a legitimate medical purpose, or, two, outside the usual course of professional practice,

4 Opinion of the Court 22-11917

then the exception to the Controlled Substances Act does not apply. . . .

You must find the prescriptions described above were not issued for legitimate medical purposes or were not issued in the usual course of professional medical practice. . . . [T]he government must prove that the defendant acted knowingly and intentionally.

Prior to reading the jury charge, the district judge asked both parties whether they had any objections to the instructions. Akwuba’s counsel responded briefly: “No, ma’am.” The district judge proceeded to read the jury charge and then take a brief recess . Again, post-delivering the lion’s share of the charge, the district judge inquired if the defense had any objections. Akwuba’s counsel objected on a ground unrelated to this appeal, which was denied. The district judge inquired for a last time whether there was anything further from defense, to which Akwuba’s counsel responded , “No, Your Honor.”

Ultimately, the jury acquitted Akwuba on the money laundering conspiracy and money laundering counts (counts 39–42) and found her guilty of all remaining counts. She was sentenced to 120 months on each count, to run concurrently, followed by three years of supervised release on each count, to run concurrently.

Akwuba appealed, and we affirmed all convictions but one (count 24) and remanded the case for resentencing in light of the vacated conviction. United States v. Akwuba, 7 F.4th 1299, 1319 (11th

22-11917 Opinion of the Court 5

Cir. 2021). Akwuba was resentenced to 120 months’ imprisonment. She again appeals her convictions and sentences.

II. Analysis

Akwuba claims (1) the evidence presented at trial was insufficient to serve as a basis for her conviction; (2) plain error, not invited error, should serve as the standard of review for her jury instructions claim, and (3) the district court plainly erred by instructing the jury on subjective good faith instead of the knowing and intentional mens rea, as recently decided by the Supreme Court in Ruan v. United States. 1 We will address each claim in turn.

A. Sufficiency of the Evidence Under 21 U.S.C. § 841(a)(1), it is a federal crime, “[e]xcept as authorized[,] . . . for any person knowingly or intentionally . . . to manufacture, distribute, or dispense, or possess with intent to manufacture , distribute, or dispense, a controlled substance.” In turn, 21 U.S.C. § 846 further makes it a federal crime to attempt or conspire to do the same. A federal regulation authorizes registered doctors to dispense Schedule II, III, and IV controlled substances with a prescription, but only if the prescription is “issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his professional practice.” 21 C.F.R. § 1306.04(a).

When reviewing the sufficiency of the evidence in a case, our court applies de novo review, but “view[s] the evidence in the

1 142 S. Ct. 2370 (2022).

6 Opinion of the Court 22-11917

light most favorable to the government and draw[s] all reasonable inferences and credibility choices in favor of the jury’s verdict.” United States v. Taylor, 480 F.3d 1025, 1026 (11th Cir. 2007). However , we decline to revisit an issue previously decided on a prior appeal under the law of the case doctrine. United States v. Jordan, 429 F.3d 1032, 1035 (11th Cir. 2005). We have acknowledged three exceptions to this mandate: “(1) a subsequent trial produces substantially different evidence, (2) controlling authority has since made a contrary decision of law applicable to that issue, or (3) the prior [appellate] decision was clearly erroneous and would work manifest injustice.” United States v. Amedeo, 487 F.3d 823, 830 (11th Cir. 2007) (emphasis added) (quoting United States v. Stinson, 97 F.3d 466, 469 (11th Cir. 1996)).

Akwuba argues that the prosecution’s evidence regarding her § 841 charges and her § 846 charge was insufficient, an argument she offered on her first appeal. She acknowledges our precedent regarding law of the case doctrine, yet firmly asserts she falls under the second exception. Akwuba directs us to the Supreme Court’s decision in Ruan, urging us, without further elaboration, that Ruan constitutes a contrary decision of law. Akwuba’s analysis misses the mark.

Free access — add to your briefcase to read the full text and ask questions with AI

United States v. Lillian Akwuba, (11th Cir. 2023).

United States v. Lillian Akwuba (United States v. Lillian Akwuba) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Frank
599 F.3d 1221 (Eleventh Circuit, 2010)
United States v. Stinson
97 F.3d 466 (Eleventh Circuit, 1996)
United States v. Stone
139 F.3d 822 (Eleventh Circuit, 1998)
United States v. Wyatt Henderson
409 F.3d 1293 (Eleventh Circuit, 2005)
United States v. Albert Jordan
429 F.3d 1032 (Eleventh Circuit, 2005)
United States v. Christopher Love
449 F.3d 1154 (Eleventh Circuit, 2006)
United States v. Jason Luntay Taylor
480 F.3d 1025 (Eleventh Circuit, 2007)
United States v. Damon Amedeo
487 F.3d 823 (Eleventh Circuit, 2007)
United States v. Cotton
535 U.S. 625 (Supreme Court, 2002)
United States v. Thomas C. Allen
772 F.2d 1555 (Eleventh Circuit, 1985)
Henderson v. United States
133 S. Ct. 1121 (Supreme Court, 2013)
United States v. Peter Hesser
800 F.3d 1310 (Eleventh Circuit, 2015)
United States v. Isaac Seabrooks
839 F.3d 1326 (Eleventh Circuit, 2016)
United States v. Anthony Moore
22 F.4th 1258 (Eleventh Circuit, 2022)
Xiulu Ruan v. United States
597 U.S. 450 (Supreme Court, 2022)
United States v. Dr. James Heaton
59 F.4th 1226 (Eleventh Circuit, 2023)
United States v. John Thomas Burnette
65 F.4th 591 (Eleventh Circuit, 2023)